Financials
- Market Capitalization 2.24 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.16
売上高対価格比率
2.79
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1772 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.65 USD | +11.88% | -2.92% | -66.71% | -61.03% | 2.79 B USD | ||
| 1792 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 46.66 USD | -1.46% | -2.49% | +5.83% | -13.59% | 2.71 B USD | ||
| 1998 | HCM HUTCHMED (China) Limited - American Depositary Shares | 11.25 USD | +0.99% | -0.09% | +6.13% | -32.84% | 1.96 B USD | ||
| 2052 | ANIP ANI Pharmaceuticals, Inc. - Common Stock | 80.55 USD | -0.65% | -5.92% | -2.59% | -14.88% | 1.83 B USD |